In 2017 the Camden Coalition of Healthcare Providers began a pilot in partnership with local addiction treatment providers and UnitedHealthCare to see if removing prior authorization requirements for buprenorphine would reduce barriers to treatment and improve patient and system outcomes.
A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Arizona’s Department of Health Services adopted an enhanced opioid data surveillance program that requires first responders and health care providers to report suspected opioid overdoses, suspected opioid overdose deaths, naloxone distribution, and naloxone administration through an electronic reporting system. Providers are also required to report suspected cases of neonatal opioid withdrawal syndrome (neonatal abstinence syndrome). In addition, the state provides blood testing from suspected opioid overdoses by the public health laboratory and has a real time opioid data online dashboard. Links the project website, copies of the executive order and regulations, frequently asked questions, and implementation guides are available below.
The Arizona Department of Health Services prepared this 2017 review of opioid related policies in all 50 states to assist decision-makers in evaluating potential policy actions. The review includes appendices which address topics such as prescribing regulations and guidelines, data collection, state substance abuse task forces, and state emergency response declarations. The reports are available for download below.
This presentation slide deck briefly reviews the evidence for the effectiveness of peer support specialists who provide mental health, substance use disorder, and family and caregiver support.
This reports provides a summary of key findings from the 2019 National Survey on Drug Use and Health which measures national indicators of substance use and mental health among noninstitutionalized individuals 12 and older. The national indicators focus on tobacco use, alcohol use, kratom use, illicit drug use, initiation of substance use, perceived risk from substance use, substance use disorders, major depressive episodes, any mental illness, serious mental illness, co-occurring major depressive episode and substance use disorder, and perceived recovery. Funding Source: Substance Abuse and Mental Health Services Administration
The Rural Community Toolbox website, created by the Office of National Drug Control Policy, provides resources to fight addiction in rural communities. The toolbox provides information about funding opportunities and technical assistance offered by 16 federal departments and agencies.
A comprehensive report on strategies to use data to inform policies to address the opioid crisis from the Rand Corporation. The report includes a review of national opioid policy priorities, reviews existing research and commonly used data sources to support these policy priorities, categorizes and describes existing data sources, and describes challenges to using data to address opioid-related issues along with strategies to address these challenges.
This report examines how 6 state Medicaid agencies have used data to develop strategies to address the opioid crisis. The report describes how states use data from medical and pharmacy claims, prescription drug monitoring projects (PDMPS), health information exchanges (HIE) and admission, discharge and transfer (ADT) databases to identify providers and patients with problematic opioid-related behaviors and what they do to address these behaviors. Case studies of initiatives in South Dakota, Minnesota and Tennessee are featured.
The Kaiser Family Foundation’s Covid-19 resources page includes data and information on federal and state responses to the public health emergency. The site has data and charts summarizing the following: